Trials / Completed
CompletedNCT05772832
COMPARISON OF DEXMEDETOMIDINE AND REMIFENTANIL FOR POSTOPERATIVE PAIN IN TRANSPHENOIDAL Pituitary SURGERY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In patients with pituitary adenoma scheduled for endoscopic transsphenoidal pituitary surgery, it was aimed to compare the efficacy of postoperative pain relief of a selective α-2 agonist "Dexmedetomidine" and the rapid and short-acting opioid "Remifentanil" using the "Numerical Rating Scale" (NRS) administered alongside propofol in perioperative maintenance anesthesia. .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Efficacy of dexmedetomidine on postoperative pain in patients undergoing transsphenoidal pituitary surgery |
| DRUG | Remifentanyl | Efficacy of remifentanyl on postoperative pain in patients undergoing transsphenoidal pituitary surgery |
Timeline
- Start date
- 2021-11-17
- Primary completion
- 2022-12-14
- Completion
- 2023-02-22
- First posted
- 2023-03-16
- Last updated
- 2025-08-27
Locations
1 site across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05772832. Inclusion in this directory is not an endorsement.